Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Renner

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Immunogenetics|April 2, 2017
The scavenging capacity of DMBT1 is impaired by germline deletionsFloris J Bikker, Caroline End, Antoon J M Ligtenberg, et al.
Epigenetics|September 6, 2016
Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinomaBenjamin Goeppert, Christina Ernst, Constance Baer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 7, 2013
BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinomaBenjamin Goeppert, Lena Frauenschuh, Marcus Renner, et al.
Histopathology|May 11, 2013
Follicle-stimulating hormone receptor expression in soft tissue sarcomasMarcus Renner, Benjamin Goeppert, Muhammad Ahsan Siraj, et al.
BMC Cancer|January 17, 2019
Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma - correlation with clinicopathological data and comparison of antibodiesMark Kriegsmann, Stephanie Roessler, Katharina Kriegsmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Regulation of DMBT1 via NOD2 and TLR4 in intestinal epithelial cells modulates bacterial recognition and invasionPhilip Rosenstiel, Christian Sina, Caroline End, et al.
International Journal of Cancer|June 19, 2015
SRC inhibition represents a potential therapeutic strategy in liposarcomaElisabeth Sievers, Marcel Trautmann, Dagmar Kindler, et al.
British Journal of Cancer|November 1, 2018
Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinomaBenjamin Goeppert, Stephanie Roessler, Marcus Renner, et al.
Hepatology (Baltimore, Md.)|May 15, 2014
Overexpression of far upstream element (FUSE) binding protein (FBP)-interacting repressor (FIR) supports growth of hepatocellular carcinomaMona Malz, Michael Bovet, Jana Samarin, et al.
Scientific Reports|December 25, 2019
Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and BoneIlka Isfort, Sandra Elges, Magdalene Cyra, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Immunogenetics|April 2, 2017
The scavenging capacity of DMBT1 is impaired by germline deletionsFloris J Bikker, Caroline End, Antoon J M Ligtenberg, et al.
Epigenetics|September 6, 2016
Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinomaBenjamin Goeppert, Christina Ernst, Constance Baer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 7, 2013
BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinomaBenjamin Goeppert, Lena Frauenschuh, Marcus Renner, et al.
Histopathology|May 11, 2013
Follicle-stimulating hormone receptor expression in soft tissue sarcomasMarcus Renner, Benjamin Goeppert, Muhammad Ahsan Siraj, et al.
BMC Cancer|January 17, 2019
Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma - correlation with clinicopathological data and comparison of antibodiesMark Kriegsmann, Stephanie Roessler, Katharina Kriegsmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Regulation of DMBT1 via NOD2 and TLR4 in intestinal epithelial cells modulates bacterial recognition and invasionPhilip Rosenstiel, Christian Sina, Caroline End, et al.
International Journal of Cancer|June 19, 2015
SRC inhibition represents a potential therapeutic strategy in liposarcomaElisabeth Sievers, Marcel Trautmann, Dagmar Kindler, et al.
British Journal of Cancer|November 1, 2018
Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinomaBenjamin Goeppert, Stephanie Roessler, Marcus Renner, et al.
Hepatology (Baltimore, Md.)|May 15, 2014
Overexpression of far upstream element (FUSE) binding protein (FBP)-interacting repressor (FIR) supports growth of hepatocellular carcinomaMona Malz, Michael Bovet, Jana Samarin, et al.
Scientific Reports|December 25, 2019
Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and BoneIlka Isfort, Sandra Elges, Magdalene Cyra, et al.
Pageof 7